Latest Insider Transactions at Beauty Health CO (SKIN)
This section provides a real-time view of insider transactions for Beauty Health CO (SKIN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Beauty Health Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Beauty Health Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 12
2024
|
Brent L Saunders Director |
BUY
Open market or private purchase
|
Direct |
40,450
+0.68%
|
$40,450
$1.08 P/Share
|
Aug 10
2024
|
Michael P. Monahan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,274
-3.9%
|
$32,274
$1.12 P/Share
|
Jul 08
2024
|
Desiree Gruber Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,534
+36.92%
|
-
|
Jul 08
2024
|
Brian Christopher Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,534
+31.6%
|
-
|
Jul 08
2024
|
Michelle C. Kerrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,534
+40.21%
|
-
|
Jul 08
2024
|
Doug K. Schillinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,534
+35.45%
|
-
|
Jul 08
2024
|
Michael D Capellas Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,534
+22.14%
|
-
|
Jul 08
2024
|
Julius Few Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,534
+28.78%
|
-
|
Jul 08
2024
|
Brent L Saunders Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,534
+1.32%
|
-
|
Apr 09
2024
|
Daniel Copell Watson Chief Revenue Oficer |
BUY
Grant, award, or other acquisition
|
Direct |
243,506
+23.14%
|
-
|
Apr 09
2024
|
Marla Malcolm Beck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
837,662
+43.72%
|
-
|
Apr 09
2024
|
Michael P. Monahan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
292,207
+26.11%
|
-
|
Apr 08
2024
|
Marla Malcolm Beck President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,439
-2.07%
|
$64,317
$3.8 P/Share
|
Apr 05
2024
|
Daniel Copell Watson Chief Revenue Oficer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,212
-1.42%
|
$33,636
$3.71 P/Share
|
Mar 20
2024
|
Marla Malcolm Beck President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,720
-1.02%
|
$42,880
$4.36 P/Share
|
Mar 01
2024
|
Daniel Copell Watson Chief Revenue Oficer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,356
-0.8%
|
$19,068
$3.73 P/Share
|
Feb 20
2024
|
Marla Malcolm Beck President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,720
-1.01%
|
$21,440
$2.98 P/Share
|
Feb 04
2024
|
Daniel Copell Watson Chief Revenue Oficer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,633
-1.32%
|
$21,266
$2.98 P/Share
|
Jan 20
2024
|
Marla Malcolm Beck President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,663
-1.0%
|
$21,326
$2.43 P/Share
|
Dec 20
2023
|
Marla Malcolm Beck President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,676
-0.99%
|
$32,028
$3.18 P/Share
|
Nov 29
2023
|
Bradley Hauser Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
176,711
+31.15%
|
-
|
Nov 29
2023
|
Daniel Copell Watson Chief Revenue Oficer |
BUY
Grant, award, or other acquisition
|
Direct |
156,250
+21.66%
|
-
|
Nov 29
2023
|
Michael P. Monahan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
176,711
+24.84%
|
-
|
Nov 20
2023
|
Marla Malcolm Beck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
213,675
+47.04%
|
-
|
Aug 17
2023
|
Brian Christopher Miller Director |
BUY
Open market or private purchase
|
Direct |
60,000
+39.62%
|
$300,000
$5.81 P/Share
|
Aug 17
2023
|
Michael D Capellas Director |
BUY
Open market or private purchase
|
Direct |
30,000
+13.18%
|
$180,000
$6.03 P/Share
|
Aug 17
2023
|
Michael P. Monahan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.38%
|
$30,000
$6.02 P/Share
|
Aug 17
2023
|
Andrew Roy Stanleick Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
16,485
+2.29%
|
$98,910
$6.05 P/Share
|
Aug 16
2023
|
Julius Few Director |
BUY
Open market or private purchase
|
Direct |
20,454
+15.01%
|
$122,724
$6.1 P/Share
|
Aug 16
2023
|
Doug K. Schillinger Director |
BUY
Open market or private purchase
|
Direct |
33,000
+33.86%
|
$198,000
$6.11 P/Share
|
Aug 16
2023
|
Brent L Saunders Director |
BUY
Open market or private purchase
|
Direct |
59,380
+1.01%
|
$356,280
$6.1 P/Share
|
Aug 10
2023
|
Michael P. Monahan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
353,107
+50.0%
|
-
|
Jul 07
2023
|
Michelle C. Kerrick Director |
BUY
Other acquisition or disposition
|
Direct |
6,779
+15.06%
|
-
|
Jul 07
2023
|
Lcp Edge Holdco LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,207,261
-8.77%
|
-
|
Jun 14
2023
|
Marla Malcolm Beck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+37.83%
|
-
|
Jun 14
2023
|
Michelle C. Kerrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+34.21%
|
-
|
Jun 14
2023
|
Michael D Capellas Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+34.21%
|
-
|
Jun 14
2023
|
Doug K. Schillinger Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+34.21%
|
-
|
Jun 14
2023
|
Julius Few Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+34.21%
|
-
|
Jun 14
2023
|
Brent L Saunders Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+0.28%
|
-
|
Jun 14
2023
|
Desiree Gruber Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+22.72%
|
-
|
Jun 14
2023
|
Brian Christopher Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,357
+34.21%
|
-
|
Apr 19
2023
|
Bradley Hauser Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
77,433
+26.58%
|
-
|
Apr 05
2023
|
Andrew Roy Stanleick Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
294,579
+30.03%
|
-
|
Apr 05
2023
|
Liyuan Woo |
BUY
Grant, award, or other acquisition
|
Direct |
117,831
+16.61%
|
-
|
Apr 05
2023
|
Daniel Copell Watson Chief Revenue Oficer |
BUY
Grant, award, or other acquisition
|
Direct |
94,265
+18.74%
|
-
|
Mar 01
2023
|
Andrew Roy Stanleick Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,536
+13.0%
|
-
|
Mar 01
2023
|
Liyuan Woo |
BUY
Grant, award, or other acquisition
|
Direct |
18,746
+3.81%
|
-
|
Mar 01
2023
|
Daniel Copell Watson Chief Revenue Oficer |
BUY
Grant, award, or other acquisition
|
Direct |
17,560
+5.29%
|
-
|
Feb 04
2023
|
Daniel Copell Watson Chief Revenue Oficer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,972
-1.1%
|
$107,664
$12.9 P/Share
|